Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

BUY
$242.49 - $301.46 $3,637 - $4,521
15 Added 0.98%
1,547 $376,000
Q2 2022

Jul 11, 2022

SELL
$224.73 - $338.64 $20,675 - $31,154
-92 Reduced 5.67%
1,532 $409,000
Q1 2022

Apr 12, 2022

SELL
$277.25 - $366.29 $6,376 - $8,424
-23 Reduced 1.4%
1,624 $487,000
Q4 2021

Jan 11, 2022

SELL
$300.63 - $371.35 $13,528 - $16,710
-45 Reduced 2.66%
1,647 $526,000
Q3 2021

Nov 03, 2021

BUY
$310.19 - $376.2 $620 - $752
2 Added 0.12%
1,692 $569,000
Q2 2021

Jul 14, 2021

SELL
$262.71 - $351.17 $120,583 - $161,187
-459 Reduced 21.36%
1,690 $539,000
Q1 2021

Apr 16, 2021

SELL
$285.92 - $355.13 $20,586 - $25,569
-72 Reduced 3.24%
2,149 $685,000
Q4 2020

Jan 13, 2021

SELL
$251.88 - $324.2 $3.61 Million - $4.64 Million
-14,318 Reduced 86.57%
2,221 $720,000
Q3 2020

Oct 13, 2020

BUY
$255.22 - $317.0 $3.35 Million - $4.16 Million
13,118 Added 383.46%
16,539 $4.58 Million
Q2 2020

Jul 21, 2020

BUY
$141.4 - $257.09 $110,150 - $200,273
779 Added 29.49%
3,421 $826,000
Q1 2020

Apr 14, 2020

BUY
$130.51 - $196.01 $17,096 - $25,677
131 Added 5.22%
2,642 $384,000
Q4 2019

Jan 29, 2020

BUY
$159.31 - $223.54 $14,656 - $20,565
92 Added 3.8%
2,511 $428,000
Q3 2019

Oct 18, 2019

BUY
$175.89 - $279.23 $122,243 - $194,064
695 Added 40.31%
2,419 $430,000
Q2 2019

Jul 25, 2019

BUY
$250.96 - $284.94 $171,656 - $194,898
684 Added 65.77%
1,724 $449,000
Q1 2019

Apr 18, 2019

BUY
$276.39 - $362.25 $58,871 - $77,159
213 Added 25.76%
1,040 $297,000
Q4 2018

Feb 06, 2019

BUY
$281.08 - $444.25 $19,675 - $31,097
70 Added 9.25%
827 $269,000
Q3 2018

Nov 05, 2018

SELL
$354.53 - $449.75 $236,471 - $299,983
-667 Reduced 46.84%
757 $340,000
Q2 2018

Aug 06, 2018

BUY
$278.07 - $446.21 $8,620 - $13,832
31 Added 2.23%
1,424 $582,000
Q1 2018

Apr 23, 2018

BUY
$192.49 - $295.85 $268,138 - $412,119
1,393 New
1,393 $405,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.